Impaired activation of the Nrf2-ARE signaling pathway undermines H 2 O 2-induced oxidative stress response: A possible mechanism for melanocyte degeneration in vitiligo

Journal of Investigative Dermatology

Volumn 134, Issue 8, 2014, Pages 2221-2230

  Jian, Zhe ^a   Li, Kai ^a   Song, Pu ^a   Zhu, Guannan ^a   Zhu, Longfei ^a   Cui, Tingting ^a   Liu, Bangmin ^a   Tang, Lingzhen ^a   Wang, Xiaowen ^a   Wang, Gang ^a   Gao, Tianwen ^a   Li, Chunying ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HEME OXYGENASE 1; HYDROGEN PEROXIDE; INTERLEUKIN 2; TRANSCRIPTION FACTOR NRF2;

ADULT; ARTICLE; BLOOD LEVEL; CELL DEGENERATION; CONTROLLED STUDY; ENZYME BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MELANOCYTE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VITILIGO;

ADULT; ANTIOXIDANT RESPONSE ELEMENTS; CATALASE; CELLS, CULTURED; FEMALE; HEME OXYGENASE-1; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-2; MALE; MELANOCYTES; MIDDLE AGED; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; VITILIGO;

EID: 84904412170     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.152     Document Type: Article

References (54)

1. Agrawal D, Shajil EM, Marfatia YS et al. (2004) Study on the antioxidant status of vitiligo patients of different age groups in Baroda. Pigment Cell Res 17:289-94
2. Arican O, Kurutas EB (2008) Oxidative stress in the blood of patients with active localized vitiligo. Acta Dermatovenerol Alp Panonica Adriat 17:12-6
3. Beazley WD, Gaze D, Panske A et al. (1999) Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 141:301-3
4. Beyer TA, Auf DKU, Braun S et al. (2007) Roles and mechanisms of action of the Nrf2 transcription factor in skin morphogenesis, wound repair and skin cancer. Cell Death Differ 14:1250-4
5. Boissy RE, Liu YY, Medrano EE et al. (1991) Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in longterm cultures of melanocytes from vitiligo patients. J Invest Dermatol 97:395-404
6. Boissy RE, Manga P (2004) On the etiology of contact/occupational vitiligo. Pigment Cell Res 17:208-14
7. Dell'Anna ML, Maresca V, Briganti S et al. (2001) Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 117:908-13
8. Dell'Anna ML, Ottaviani M, Albanesi V et al. (2007) Membrane lipid alterations as a possible basis for melanocyte degeneration in vitiligo. J Invest Dermatol 127:1226-33
9. Dinkova-Kostova AT, Holtzclaw WD, Cole RN et al. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99:11908-13
10. Gauthier Y, Cario AM, Taieb A (2003) A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy Pigment Cell Res 16:322-32
11. Harvey CJ, Thimmulappa RK, Singh A et al. (2009) Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med 46:443-53
12. Hayes JD, McMahon M (2001) Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett 174:103-13
13. Hazneci E, Karabulut AB, Ozturk C et al. (2005) A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients. Int J Dermatol 44:636-40
14. Im S, Hann SK, Kim HI et al. (1994) Biologic characteristics of cultured human vitiligo melanocytes. Int J Dermatol 33:556-62
15. Ines D, Sonia B, Riadh BM et al. (2006) A comparative study of oxidantantioxidant status in stable and active vitiligo patients. Arch Dermatol Res 298:147-52
16. Iyengar B, Misra RS (1988) Neural differentiation of melanocytes in vitiliginous skin. Acta Anat (Basel) 133:62-5
17. Jian Z, Li K, Liu L et al. (2011) Heme oxygenase-1 protects human melanocytes from H(2)O(2)-induced oxidative stress via the Nrf2-ARE pathway. J Invest Dermatol 131:1420-7
18. Jimbow K, Chen H, Park JS et al. (2001) Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 144:55-65
19. Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89-116
20. Khan R, Gupta S, Sharma A (2012) Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-beta) in patients with vitiligo. J Am Acad Dermatol 66:510-1
21. Khan R, Satyam A, Gupta S et al. (2009) Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo. Arch Dermatol Res 301:731-7
22. Kim HJ, Vaziri ND (2010) Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol 298:F662-71
23. Kim NH, Jeon S, Lee HJ et al. (2007) Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes. J Invest Dermatol 127:2612-7
24. Koca R, Armutcu F, Altinyazar HC et al. (2004) Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 29:406-9
25. Kroll TM, Bommiasamy H, Boissy RE et al. (2005) 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: Relevance to vitiligo. J Invest Dermatol 124:798-806
26. Le PI, Boissy RE, Sarangarajan R et al. (2000) PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol Anim 36:309-19
27. Le PI, Das PK, van den Wijngaard RM et al. (1993) Review of the etiopathomechanism of vitiligo: A convergence theory. Exp Dermatol 2:145-53
28. Le PI, van den Berg FM, van den Wijngaard RM et al. (1997) Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes. In Vitro Cell Dev Biol Anim 33:42-9
29. Lee AY, Kim NH, Choi WI et al. (2005) Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J Invest Dermatol 124:976-83
30. Lluis JM, Buricchi F, Chiarugi P et al. (2007) Dual role of mitochondrial reactive oxygen species in hypoxia signaling: Activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res 67:7368-77
31. Maresca V, Roccella M, Roccella F et al. (1997) Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 109:310-3
32. Marrot L, Jones C, Perez P et al. (2008) The significance of Nrf2 pathway in (photo)-oxidative stress response in melanocytes and keratinocytes of the human epidermis. Pigment Cell Melanoma Res 21:79-88
33. Pae HO, Oh GS, Choi BM et al. (2004) Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 172:4744-51
34. Passi S, Grandinetti M, Maggio F et al. (1998) Epidermal oxidative stress in vitiligo. Pigment Cell Res 11:81-5
35. Paupe V, Dassa EP, Goncalves S et al. (2009) Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS One 4:e4253
36. Picardo M, Passi S, Morrone A et al. (1994) Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 7:110-5
37. Puri N, Mojamdar M, Ramaiah A (1987) In vitro growth characteristics of melanocytes obtained from adult normal and vitiligo subjects. J Invest Dermatol 88:434-8
38. Rubin LA, Nelson DL (1990) The soluble interleukin-2 receptor: Biology, function, and clinical application. Ann Intern Med 113:619-27
39. Schallreuter KU, Bahadoran P, Picardo M et al. (2008) Vitiligo pathogenesis: Autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else Exp Dermatol 17:139-40, 141-60
40. Schallreuter KU, Gibbons NC, Zothner C et al. (2007) Hydrogen peroxidemediated oxidative stress disrupts calcium binding on calmodulin: More evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 360:70-5
41. Schallreuter KU, Moore J, Wood JM et al. (1999) In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 4:91-6
42. Schallreuter KU, Wood JM, Berger J (1991) Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 97:1081-5
43. Shajil EM, Begum R (2006) Antioxidant status of segmental and non-segmental vitiligo. Pigment Cell Res 19:179-80
44. Shalbaf M, Gibbons NC, Wood JM et al. (2008) Presence of epidermal allantoin further supports oxidative stress in vitiligo. Exp Dermatol 17:761-70
45. Shunsuke T, Makoto F, Hou DX (2007) Action of Nrf2 and Keap1 in AREmediated NQO1 expression by quercetin. Free Radic Biol Med 42: 1690-703
46. Spritz RA (2008) The genetics of generalized vitiligo. Curr Dir Autoimmun 10:244-57
47. Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768-80
48. Taieb A (2000) Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res 13(Suppl 8):41-7
49. Tanaka A, Hamada N, Fujita Y et al. (2010) A novel kavalactone derivative protects against H2O2-induced PC12 cell death via Nrf2/ARE activation. Bioorg Med Chem 18:3133-9
50. Tusi SK, Ansari N, Amini M et al. (2010) Attenuation of NF-kappaB and activation of Nrf2 signaling by 1,2,4-triazine derivatives, protects neuronlike PC12 cells against apoptosis. Apoptosis 15:738-51
51. van den Wijngaard RM, Asghar SS, Pijnenborg AC et al. (2002) Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo. Br J Dermatol 146:80-7
52. Yildirim M, Baysal V, Inaloz HS et al. (2004) The role of oxidants and antioxidants in generalized vitiligo at tissue level. J Eur Acad Dermatol Venereol 18:683-6
53. Yildirim M, Baysal V, Inaloz HS et al. (2003) The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 30:104-8
54. Zhu H, Itoh K, Yamamoto M et al. (2005) Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: Protection against reactive oxygen and nitrogen species-induced cell injury. FEBS Lett 579:3029-36